JC: Canadian TIA risk score. St Emlyn’s
We see a lot of patients in the ED with a history of what sounds very much like a transient ischaemic event (TIA). By definition the patient will have had […]
JC: Canadian TIA risk score. St Emlyn’s Read More
We see a lot of patients in the ED with a history of what sounds very much like a transient ischaemic event (TIA). By definition the patient will have had […]
JC: Canadian TIA risk score. St Emlyn’s Read More
Oxygen targets in critically ill/injured patients has been something we’ve talked about on the blog before. In general the evidence to date has suggested that the routine prescription of oxygen
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s Read More
Rick Body has once again put together a great COVID-19 podcast to update us on the latest vaccines roll out in the UK. Prof. Rick Body, Prof. Simon Carley, Prof.
Vaccines update January 2021: St Emlyn’s Read More
This week I’m (virtually) attending the RCEM Research Engagement Day. This annual event combined an academic trainee day (14th) together with a more general day looking at research in a
#FOAMed for academics: A primer. St Emlyn’s Read More
We have been following the RECOVERY trial closely over the last few months. It’s the largest RCT of therapeutics for COVID-19 in the world and it’s already shown that hydroxychloroquine
JC: Lopinavir/Ritonavir in the treatment of COVID-19 Read More
A core skill in emergency medicine is in the identification and classification of risk categories for the patients we see. For many conditions we have derived, validated and refined scoring
Risk stratification in the ED for COVID19 patients: The PRIEST study. St Emlyn’s Read More
This week Simon and Rick got together to talk through the latest technologies, uses and performance of COVID-19 testing. We think it’s a really useful listen to understand the strengths
Understanding COVID-19 testing with Rick Body. St Emlyn’s Read More
This month the BMJ has published a trial on the use of convalescent plasma in the treatment of admitted patients with COVID-19 (the PLACID trial). Convalescent plasma therapy basically takes
JC: Convalescent plasma in COVID 19 patients. Read More